Detected ·
Neusignal Therapeutics
$36M—
Neusignal Therapeutics completed $36M Series B financing to advance NTX-083 for Alzheimer's disease treatment, with proceeds supporting a planned Phase 1b clinical trial.
- Website
- —
- —
- Amount
- $36 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-07-13 12:53:28 UTC
- Signal ID
- edaa3704-488b-4159-ba54-e6785c594f25
As the API returns it
{
"id": "edaa3704-488b-4159-ba54-e6785c594f25",
"created_at": "2026-07-13T12:53:28.492388Z",
"company_name": "Neusignal Therapeutics",
"company_website_url": null,
"company_linkedin_url": null,
"event_type": "funding",
"funding_amount": 36000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*Neusignal Therapeutics completed $36M Series B financing to advance NTX-083 for Alzheimer's disease treatment, with proceeds supporting a planned Phase 1b clinical trial.*"
}